AKAP12 and cancer: AKAP12 has been investigated as a tumor suppressant in some human primary cancers, including GC [62,63]; however, in the present study, we found it significantly over-expressed in the TMEsubtype-H high-risk group, suggesting an increased risk of OS with higher expression levels.